Home
Add Document
Sign In
Create An Account
Table S1.xlsx - PLOS
Recommend Documents
No documents
Table S1.xlsx - PLOS
Download PDF
0 downloads
0 Views
72KB Size
Report
Comment
inhibition of control specific binding with 10 μM C1. 5-HT transporter (h) (antagonist radioligand). 5. 5 α1 (h) (agonist radioligand). -3. -1. A1 (h) (antagonist ...
Cerep Assay Name 5‐HT transporter (h) (antagonist radioligand) 1 (h) (agonist radioligand) A1 (h) (antagonist radioligand) 1 (non‐selective) (antagonist radioligand) 2 (h) (agonist radioligand) 2 (non‐selective) (antagonist radioligand) A2A (h) (agonist radioligand) A3 (h) (agonist radioligand) AMPA (agonist radioligand) AR (h) (agonist radioligand) AT1 (h) (antagonist radioligand) AT2 (h) (agonist radioligand) B1 (h) (agonist radioligand) B2 (h) (agonist radioligand) BLT1 (LTB4) (h) (agonist radioligand) BZD (central) (agonist radioligand) Ca2+ channel (L, dihydropyridine site) (antagonist radioligand) Ca2+ channel (L, diltiazem site) (benzothiazepines) (antagonist radioligand) Ca2+ channel (L, verapamil site) (phenylalkylamine) (antagonist radioligand) CB1 (h) (agonist radioligand) CB2 (h) (agonist radioligand) CCK1 (CCKA) (h) (agonist radioligand) CCK2 (CCKB) (h) (agonist radioligand) choline transporter (CHT1) (h) (antagonist radioligand) Cl‐channel (GABA‐gated) (antagonist radioligand) CRF1 (h) (agonist radioligand) CysLT1 (LTD4) (h) (agonist radioligand) D1 (h) (antagonist radioligand) D2S (h) (antagonist radioligand) D3 (h) (antagonist radioligand) D4.4 (h) (antagonist radioligand) dopamine transporter (h) (antagonist radioligand) EP2 (h) (agonist radioligand) ER (non‐selective) (h) (agonist radioligand) ETA (h) (agonist radioligand) ETB (h) (agonist radioligand) GABA (non‐selective) (agonist radioligand) GABA transporter (antagonist radioligand) H1 (h) (antagonist radioligand) H2 (h) (antagonist radioligand) H3 (h) (agonist radioligand) I2 (antagonist radioligand) IP (PGI2) (h) (agonist radioligand) kainate (agonist radioligand) KATP channel (antagonist radioligand) KV channel (antagonist radioligand) M (non‐selective) (antagonist radioligand) MC4 (h) (agonist radioligand) Na+ channel (site 2) (antagonist radioligand) NK1 (h) (agonist radioligand) NK2 (h) (agonist radioligand) NK3 (h) (antagonist radioligand) NMDA (antagonist radioligand) NOP (ORL1) (h) (agonist radioligand) norepinephrine transporter (h) (antagonist radioligand) (non‐selective) (agonist radioligand) opioid (non‐selective) (antagonist radioligand) P2X (agonist radioligand) P2Y (agonist radioligand) PCP (antagonist radioligand) PPAR (h) (agonist radioligand) PR (h) (agonist radioligand) TRH1 (h) (agonist radioligand) V1a (h) (agonist radioligand) V2 (h) (agonist radioligand) Y (non‐selective) (agonist radioligand)
% inhibition of control specific binding with 10 μM 4b 5 ‐3 7 3 2 0 0 8 ‐23 ‐2 ‐18 4 5 ‐1 2 4 ‐4 ‐15 7 7 0 72 0 14 0 0 0 ‐10 3 10 13 2 15 2 ‐19 ‐4 14 ‐12 10 ‐8 0 5 ‐15 ‐9 ‐5 2 13 1 7 7 5 0 1 ‐2 0 26 ‐15 ‐3 ‐4 15 13 0 9 10 6 ‐3
% inhibition of control specific binding with 10 μM C1 5 ‐1 9 5 2 13 9 11 ‐29 3 ‐13 12 ‐2 ‐5 0 22 ‐7 ‐3 19 18 3 68 3 40 0 ‐2 0 27 2 11 31 23 24 4 2 ‐7 5 ‐13 45 ‐11 8 73 ‐19 ‐1 5 3 20 0 41 9 9 4 ‐4 ‐2 30 30 40 5 ‐2 ‐5 13 1 1 11 5 ‐5
×
Report "Table S1.xlsx - PLOS"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
×
Sign In
Email
Password
Remember me
Forgot password?
Sign In
Our partners will collect data and use cookies for ad personalization and measurement.
Learn how we and our ad partner Google, collect and use data
.
Agree & close